ACG clinical guideline: evaluation of abnormal liver chemistries
PY Kwo, SM Cohen, JK Lim - … journal of the American College of …, 2017 - journals.lww.com
PY Kwo, SM Cohen, JK Lim
Official journal of the American College of Gastroenterology| ACG, 2017•journals.lww.comClinicians are required to assess abnormal liver chemistries on a daily basis. The most
common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate
aminotransferase (AST), alkaline phosphatase and bilirubin. These tests should be termed
liver chemistries or liver tests. Hepatocellular injury is defined as disproportionate elevation
of AST and ALT levels compared with alkaline phosphatase levels. Cholestatic injury is
defined as disproportionate elevation of alkaline phosphatase level as compared with AST …
common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate
aminotransferase (AST), alkaline phosphatase and bilirubin. These tests should be termed
liver chemistries or liver tests. Hepatocellular injury is defined as disproportionate elevation
of AST and ALT levels compared with alkaline phosphatase levels. Cholestatic injury is
defined as disproportionate elevation of alkaline phosphatase level as compared with AST …
Abstract
Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests should be termed liver chemistries or liver tests. Hepatocellular injury is defined as disproportionate elevation of AST and ALT levels compared with alkaline phosphatase levels. Cholestatic injury is defined as disproportionate elevation of alkaline phosphatase level as compared with AST and ALT levels. The majority of bilirubin circulates as unconjugated bilirubin and an elevated conjugated bilirubin implies hepatocellular disease or cholestasis. Multiple studies have demonstrated that the presence of an elevated ALT has been associated with increased liver-related mortality. A true healthy normal ALT level ranges from 29 to 33 IU/l for males, 19 to 25 IU/l for females and levels above this should be assessed. The degree of elevation of ALT and or AST in the clinical setting helps guide the evaluation. The evaluation of hepatocellular injury includes testing for viral hepatitis A, B, and C, assessment for nonalcoholic fatty liver disease and alcoholic liver disease, screening for hereditary hemochromatosis, autoimmune hepatitis, Wilson’s disease, and alpha-1 antitrypsin deficiency. In addition, a history of prescribed and over-the-counter medicines should be sought. For the evaluation of an alkaline phosphatase elevation determined to be of hepatic origin, testing for primary biliary cholangitis and primary sclerosing cholangitis should be undertaken. Total bilirubin elevation can occur in either cholestatic or hepatocellular diseases. Elevated total serum bilirubin levels should be fractionated to direct and indirect bilirubin fractions and an elevated serum conjugated bilirubin implies hepatocellular disease or biliary obstruction in most settings. A liver biopsy may be considered when serologic testing and imaging fails to elucidate a diagnosis, to stage a condition, or when multiple diagnoses are possible.
![](/scholar/images/qa_favicons/lww.com.png)